Press Release / Media Release
Zydus receives final approval from the USFDA for Doxycycline Hyclate Tablets USP31-10-2017
31-10-2017
Zydus Cadila gets USFDA nod for skin ointment
Zydus Cadila has received approval from the US health regulator to market Clobetasol Propionate ointment, used to treat a range of skin conditions, in the American market. The company has...30-10-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Clobetasol Propionate Ointment USP30-10-2017
Zydus Cadila gets USFDA nod to market breast cancer drug
Drug firm Zydus Cadila today said it has received final approval from the United States Food and Drug Administration (USFDA) to market Tamoxifen Citrate Tablets USP in the strengths of 10 mg (base)...28-10-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Tamoxifen Citrate Tablets USP.28-10-2017
Zydus Cadila gets USFDA approval to market Allopurinol tablets
The product will be manufactured at the group's formulations manufacturing facility at Baddi14-10-2017
Zydus Cadila gets USFDA nod for anti-depression drug
Zydus Cadila has received final approval from the US health regulator to market desvenlafaxine extended release tablets, used to treat depression. Approval from the United States Food and Drug...12-10-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Desvenlafaxine Extended-Release Tablets.12-10-2017
Board Meeting On November 14, 2017
We hereby inform that the meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017 to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2017. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain...11-10-2017
Compliance Certificate For The Half Year Ended On September 30, 2017.
Compliance Certificate for the half year ended on September 30, 2017.07-10-2017